Uhmontpellier
Montpellier, 34295, France
NCT Number: NCT04795297
.During one year all the resected basal cell carcinomas (BCC) analyzed in Montpellier University Hospital Anatomopathology unit were included in this study. Localisation and histological characteristics were collected. All the recurrences of BCC were searched from the medical records (or histopathology request form).
From 804 BCC, 48 were recurrent BCC with or without complete first resection. Patients with recurrent BCC were contacted to obtain agreement and more informations about the first resection and some clinical informations like sun exposure and phototype.
The statistical analysis focused on the localisation of recurrent BCC (with a complete first resection) compared to localisations of primary BCC in this population. The goal was to identified localisations with an increased risk of recurrences.
Looking for future studies?
Notify Me16 year–99 year
All sexes
Observational
Montpellier, 34295, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Cohort :
Inclusion criteria
Exclusion criteria
Cases :
Inclusion criteria
-Recurrent BCC with complete first resection
Exclusion criteria
Time frame: 1 day
Time frame: 1 day
Analysis of correlation between localisation and histology characteristics
Time frame: 1 day
Analysis of correlation between histological type and recurrence risk
Time frame: 1 day
Analysis if there is a difference between first resection histological type and the recurrent histological type
University Hospital, Montpellier
Other
Observational Study of Basal Cell Carcinoma Operated at Montpellier University Hospital and Millau Hospital From February 2020 to February 2021 - Study of Correlation Between Localisation and Recurrence, and Other Criterias
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04552990
BCC, BCC - Basal Cell Carcinoma
New York, United States
View Trial DetailsNCT00833417
Basal Cell Carcinoma, Carcinoma
Scottsdale, Arizona, United States
View Trial DetailsNCT00959647
Adnexal Diseases, Basal Cell Carcinoma
Scottsdale, Arizona, United States
View Trial DetailsNCT02667574
Basal Cell Carcinoma, Carcinoma
Besançon, France
View Trial Details